Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 19- Open
- $204.02
- 52-wk high
- $216.72
- High
- $215.97
- 52-wk low
- $35.42
- Low
- $203.18
- Prev close
- $203.71
Smart money
Earnings
Earnings came in 21.2% below what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| Cost of what it sold | — | $4.7M | $4.5M | — |
| Gross profit | — | -$4.7M | -$4.5M | — |
| What it spent | ||||
| Research and development | $262.5M | $292.6M | $344.0M | $394.9M |
| Sales and admin | $52.8M | $64.3M | $101.3M | $110.2M |
| Other operating costs | — | — | -$4.5M | — |
| Total operating expenses | $315.3M | $356.9M | $440.7M | $505.1M |
| What was left | ||||
| Operating profit | -$315.3M | -$361.6M | -$445.2M | -$505.1M |
| Interest on debt | $11.4M | $11.9M | $12.2M | $23.8M |
| Profit before tax | -$305.2M | -$364.9M | -$453.8M | -$644.4M |
| Net profit | -$305.2M | -$364.9M | -$453.8M | -$644.4M |
| EBITDA | -$289.4M | -$348.3M | -$437.1M | -$620.6M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bullish
Tone of tracked coverage
Price to book forward of Revolution Medicines, Inc. – NASDAQ:RVMDW
NeutralAug 19Is Revolution Medicines (RVMD) Fully Valued After Its BeOne Collaboration Deal?
NeutralAug 18Why Revolution Medicines (RVMD) Stock Is Up Today
BullishAug 17